Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

Bullboard Posts

Comment by mineoneon Dec 23, 2007 11:32am

387 Views

Post# 14117831

RE: from Casey energy speculator

If it wasn't for the PP shares coming free trading I think we would have held much higher. I think now that the new year is almost upon us this stock will keep trickling up. Definitely my best holding BY FAR. Have a good holiday everyone. Only 33000 on the ask from 64 to 85 cents as of close friday. This from TSX.com Will be calling regarding the Casey article and to see if stockpiling ore yet. Mineone

Bullboard Posts

How to find good AI investments